Why Submit to Blood Advances?

• In continuous publication since 2016, Blood Advances provides more peer-reviewed hematology research than any other academic journal worldwide and is an online only, open-access journal.
• Blood Advances editors are experts within the field of hematology and manuscripts are reviewed by prominent specialists.

Quick Decisions

17 Days from submission to 1st Decision
(average for unsolicited submissions)

Google Scholar

Blood Advances is the #3 rated publication by Google Scholar in the hematology category

Limited Revisions

On average, accepted papers go through no more than 2 rounds of revision

Article Alerts

Request an alert informing you that your article has been cited and/or commented on

Advance Notice & Blood Advances Highlights

A newsletter featuring the hottest studies, selected by the Editor-in-Chief and Deputy Editor

"Blood Advances in a Different Vein"

Prominent clinical research papers published in Blood Advances are highlighted in ASH Clinical News

ASH Press Release Program

Selected articles are promoted using a targeted strategy to media outlets and journalists

Open Access

All Blood Advances articles are publicly available

Highly Cited

Journal Impact Factor (JIF) 2023: 7.4
Citation impact score, CiteScore for 2023: 12.7, ranking in the 88th percentile for hematology